CSPC Pharmaceutical Group Limited Just Recorded A 20% Revenue Beat: Here's What Analysts Think
May 29
Hong Kong (HSI) Pharma Industry Analysis
UpdatedMay 29, 2024
DataAggregated Company Financials
Companies40
- 7D-1.1%
- 3M6.8%
- 1Y-4.3%
- YTD-2.3%
Over the last 7 days, the Pharma industry has dropped 1.1%, driven by Hansoh Pharmaceutical Group declining 5.5%. Overall the industry is down 4.3% in 12 months. Looking forward, earnings are forecast to grow by 12% annually.
Industry Valuation and Performance
Has the Hong Kong Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 30 May 2024 | HK$469.8b | HK$463.7b | HK$33.9b | 8.6x | 13.9x | 1x |
| Sat, 27 Apr 2024 | HK$458.9b | HK$463.7b | HK$33.8b | 7.5x | 13.6x | 1x |
| Mon, 25 Mar 2024 | HK$460.5b | HK$469.8b | HK$32.8b | 7.8x | 14.1x | 1x |
| Wed, 21 Feb 2024 | HK$434.0b | HK$470.8b | HK$33.6b | 7.5x | 12.9x | 0.9x |
| Fri, 19 Jan 2024 | HK$433.0b | HK$471.4b | HK$33.6b | 7.1x | 12.9x | 0.9x |
| Sun, 17 Dec 2023 | HK$489.7b | HK$472.9b | HK$33.8b | 8x | 14.5x | 1x |
| Tue, 14 Nov 2023 | HK$491.5b | HK$469.1b | HK$31.9b | 7x | 15.4x | 1x |
| Thu, 12 Oct 2023 | HK$437.8b | HK$469.2b | HK$31.5b | 7x | 13.9x | 0.9x |
| Sat, 09 Sep 2023 | HK$421.1b | HK$468.7b | HK$31.5b | 6.8x | 13.4x | 0.9x |
| Mon, 07 Aug 2023 | HK$471.7b | HK$446.7b | HK$27.9b | 9x | 16.9x | 1.1x |
| Wed, 05 Jul 2023 | HK$507.6b | HK$446.1b | HK$27.8b | 9.8x | 18.3x | 1.1x |
| Fri, 02 Jun 2023 | HK$503.3b | HK$448.5b | HK$27.9b | 8.5x | 18x | 1.1x |
| Sun, 30 Apr 2023 | HK$570.4b | HK$453.4b | HK$28.5b | 8.9x | 20x | 1.3x |
| Tue, 28 Mar 2023 | HK$546.4b | HK$444.2b | HK$34.0b | 9.1x | 16.1x | 1.2x |
| Thu, 23 Feb 2023 | HK$606.0b | HK$444.8b | HK$35.2b | 11x | 17.2x | 1.4x |
| Sat, 21 Jan 2023 | HK$636.0b | HK$447.4b | HK$35.6b | 10.7x | 17.9x | 1.4x |
| Mon, 19 Dec 2022 | HK$617.3b | HK$441.6b | HK$34.7b | 10.6x | 17.8x | 1.4x |
| Wed, 16 Nov 2022 | HK$621.4b | HK$439.0b | HK$34.3b | 9.4x | 18.1x | 1.4x |
| Fri, 14 Oct 2022 | HK$512.8b | HK$514.0b | HK$39.0b | 7.8x | 13.1x | 1x |
| Sun, 11 Sep 2022 | HK$549.4b | HK$520.9b | HK$40.9b | 9.7x | 13.4x | 1.1x |
| Tue, 09 Aug 2022 | HK$593.4b | HK$512.4b | HK$51.8b | 8x | 11.4x | 1.2x |
| Thu, 07 Jul 2022 | HK$652.3b | HK$514.0b | HK$52.1b | 9.4x | 12.5x | 1.3x |
| Sat, 04 Jun 2022 | HK$565.5b | HK$515.9b | HK$52.1b | 8.8x | 10.8x | 1.1x |
| Mon, 02 May 2022 | HK$580.6b | HK$516.4b | HK$51.8b | 8.5x | 11.2x | 1.1x |
| Wed, 30 Mar 2022 | HK$656.7b | HK$509.9b | HK$48.8b | 11.4x | 13.5x | 1.3x |
| Fri, 25 Feb 2022 | HK$670.3b | HK$499.3b | HK$44.1b | 9.7x | 15.2x | 1.3x |
| Sun, 23 Jan 2022 | HK$733.2b | HK$497.7b | HK$43.9b | 9.9x | 16.7x | 1.5x |
| Tue, 21 Dec 2021 | HK$686.0b | HK$496.7b | HK$43.8b | 8.6x | 15.7x | 1.4x |
| Thu, 18 Nov 2021 | HK$702.4b | HK$495.1b | HK$43.3b | 9.5x | 16.2x | 1.4x |
| Sat, 16 Oct 2021 | HK$730.1b | HK$490.5b | HK$42.5b | 10.2x | 17.2x | 1.5x |
| Mon, 13 Sep 2021 | HK$800.0b | HK$489.5b | HK$42.4b | 11.3x | 18.9x | 1.6x |
| Wed, 11 Aug 2021 | HK$907.3b | HK$489.5b | HK$42.4b | 12x | 21.4x | 1.9x |
| Sun, 06 Jun 2021 | HK$1.1t | HK$463.7b | HK$30.0b | 15.3x | 36.1x | 2.3x |
Price to Earnings Ratio
36.1x
Current Industry PE
- Investors are pessimistic on the Hong Kong Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 13.9x which is lower than its 3-year average PE of 16.1x.
- The 3-year average PS ratio of 1.3x is higher than the industry's current PS ratio of 1.0x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have grown 4.2% per year over the last three years, while revenues have remained mostly flat.
- This means that companies overall are more efficiently conducting business since profits are increasing while sales have been flat.
Industry Trends
Which industries have driven the changes within the Hong Kong Healthcare industry?
| HK Market | -0.73% | |
| Healthcare | -3.70% | |
| Pharma | -1.09% | |
| Pharma | -1.09% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 1093 CSPC Pharmaceutical Group | HK$6.75 | 3.7% +HK$2.8b | -1.0% | PE12.2x | |
| 867 China Medical System Holdings | HK$6.98 | 2.9% +HK$487.9m | -36.5% | PE6.6x | |
| 512 Grand Pharmaceutical Group | HK$4.86 | 0.4% +HK$70.0m | -4.3% | PE9.1x | |
| 8049 Jilin Province Huinan Changlong Bio-pharmacy | HK$1.59 | 5.3% +HK$44.8m | -1.9% | PE5.6x | |
| 575 Regent Pacific Group | HK$0.64 | 39.1% +HK$41.1m | -23.8% | PS64.3x |
